1.
Bazzichi L, Biasi D, Tinazzi E, Muratore M, Pellerito R, Russo R, Corsaro Santi M, De Sandre P, Epis O, Granata M, Kroegler B, Meschini C, Versace F, Astolfi C. Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study. Reumatismo [Internet]. 2014Nov.6 [cited 2020Aug.15];66(3):224-32. Available from: https://www.reumatismo.org/index.php/reuma/article/view/reumatismo.2014.748